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ABSTRACT
Malignant pericardial mesothelioma is a rare and progressive cardiac tumor. There is no established standard treatment and 
the prognosis is poor. Most patients were retrospectively diagnosed from surgery or autopsy due to absence of specific clini-
cal manifestation. Most patients with pericardial mesothelioma have demonstrated constrictive physiology on echocardiog-
raphy or cardiac catheterization. Therefore, pericardial mesothelioma was often misdiagnosed as other causes of constrictive 
pericarditis. We report a case of primary pericardial mesothelioma misdiagnosed as pericardial metastasis of unknown ori-
gin. (Korean Circ J 2011;41:338-341)
KEY WORDS: Pericardium; Mesothelioma; Constrictive pericarditis.
Received: August 20, 2010
Revision Received: September 27, 2010
Accepted: October 7, 2010
Correspondence: Dae Hyeok Kim, MD, Division of Cardiology, Depart-
ment of Internal Medicine, Inha University College of Medicine, 7-206   
Sinheung-dong 3-ga, Jung-gu, Incheon 400-711, Korea
Tel: 82-32-890-2440, Fax: 82-32-890-2447
E-mail: kdhmd@inha.ac.kr
• The authors have no financial conflicts of interest.
cc This is an Open Access article distributed under the terms of the Cre-
ative Commons Attribution Non-Commercial License (http://creativecom-
mons.org/licenses/by-nc/3.0) which permits unrestricted non-commer-
cial use, distribution, and reproduction in any medium, provided the origi-
nal work is properly cited.
 Introduction
Malignant pericardial mesothelioma is an extremely rare 
and progressive cardiac tumor. Its clinical manifestations are 
nonspecific. Echocardiography, computed tomography (CT) 
and magnetic resonance imaging (MRI) may be used as sum-
mative diagnostic tools to support correct diagnosis. However, 
most malignant pericardial mesotheliomas have been diag-
nosed by histology, including immunohistochemical stain-
ing, after surgery or autopsy. To determine the exact etiology 
of constrictive pericarditic disease, clinical suspicion and con-
firmative evaluation are needed in patients who exhibit the 
physiology of constrictive pericarditis in transthoracic echo-
cardiography (TTE) or catheterization. There is no establi-
shed standard treatment and the prognosis remains poor. 
Case
A 59 year-old woman presented to our hospital with a two-
month history of intermittent shortness of breath and bilat-
eral lower extremities edema. Otherwise her medical history 
was unremarkable. Arterial blood gas analysis showed no 
hypoxemia or hypercapnea, and serum liver function and kid-
ney function test results were within the normal range. Chest 
radiograph revealed cardiomegaly. A 12-lead electrocardi-
ography showed nonspecific findings. TTE demonstrated 
enlarged right atrium and ventricle associated with pericar-
dial thickening around the posterior cardiac border (Fig. 1A) 
without pericardial effusion. TTE also showed dilated infe-
rior vena cava (IVC) and IVC plethora. Echocardiographic 
Doppler examination demonstrated mitral flow early diastolic 
velocity decreased with inspiration and increased with expi-
ration (Fig. 1B). The difference in peak early diastolic velocity 
between inspiration and expiration was approximately 30%. 
In addition, diastolic flow reversal of hepatic vein in expirato-
ry phase was also demonstrated. Cardiac catheterization de-
monstrated rapid rising of early diastolic pressures and abrupt 
equalization in both ventricles, namely dip and plateau pat-
tern (Fig. 2). Thoracic CT demonstrated pericardial thicken-
ing with multiple pericardial nodules, bilateral pleural effu-
sion and lymphadenopathy in the cardiophrenic area (Fig. 3A). 
Abdomen CT demonstrated aortocaval lymphadenopathy 
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chyma with periportal edema. We initially considered a diag-
nosis of malignancy of unknown origin with pericardial in-
volvement. The first thoracoscopic pericardial biopsy revealed 
no malignant cells. Flexible gastroscopy, colonoscopy and br-
east ultrasonography showed no remarkable findings. F-18 
fluorodeoxyglucose (FDG) positron emission tomography 
(PET) CT showed several hypermetabolic nodules in the pe-
ricardium, and the maximum standardized uptake value was 
6.18 (Fig. 3B). However, no additional hypermetabolic le-
sions were noted (Fig. 3D). Primary pericardial malignancy 
was highly suspected from the imaging results. Thus, a second 
pericardial biopsy was planned. Pericardiectomy and explo-
ration via sternotomy was performed to search malignancy tis-
sue and to relieve symptoms. Microscopic examination reveal-
ed malignant mesothelioma of the epitheloid type. Immuno-
histochemical staining with calretinin and D2-40 (podoplan-
in) were positive, and with CEA and TTF-1 were negative (Fig. 
4). Because the pericardium was the only lesion visible on 
PET-CT and there was no evidence of primary cancer origin 
in other organs, the patient was finally diagnosed with prima-
ry malignant pericardial mesothelioma. 
The patient had taken sixth cycles of combination chemo-
therapy with pemetrexed and carboplatin. After chemother-
apy, repeat thoracic CT showed similar cancer volume com-
pared to that obtained on imaging prior to chemotherapy. 
She is still alive 8 months after diagnosis and is currently on 
conservative management. 
Discussion
Malignant pericardial tumors are rare causes of cardiac tu-
mors. Secondary tumors are more common causes of cardi-
ac tumors, which originate mostly from the lung, breast, me-
lanomas, lymphoma, or leukemia. The incidence of malignant 
pericardial involvement with an underlying malignancy has 
been reported between 0.15 and 21% in the literature, of all 
patients with an underlying malignancy.
1) Primary malignant 
pericardial mesothelioma is extremely rare, although it is the 
most common primary malignant pericardial tumor. Its incid-
ence was 0.0022% among 500,000 cases in an autopsy study.
2) 
The clinical manifestation of malignant pericardial meso-
thelioma is nonspecific. Common clinical manifestations of 
pericardial tumors include constrictive pericarditis, pericar-
dial effusion, cardiac tamponade, and heart failure caused by 
myocardial infiltration.
3) Pericardial mesothelioma can often 
be misdiagnosed as other cause of constrictive pericarditis 
prior to undergoing pericardial tissue biopsy. Clinical suspi-
cion is the most important factor for correct diagnosis. Echo-
cardiographic evaluation is the most commonly used diag-
nostic tool. Cardiac catheterization examination can demon-
strate constrictive physiology, which shows a dip and plateau 
pattern.
4) MRI and CT used to aid making diagnosis. CT 
A   B  
Fig. 1. A: transthoracic echocardiography demonstrated pericardial thickening (arrow) without pericardial effusion on the short axis view. B: 
Doppler echocardiography demonstrated difference in peak early diastolic velocity between inspiration (blue 1) and expiration (blue 2). LV: 
left ventricle, RV: right ventricle.
Fig. 2. Cardiac catheterization demonstrated rapid rising of early 
diastolic pressures and abrupt equalization in both ventricles (red 
arrow), namely the dip and plateau pattern. Diastolic pressures of 
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scan can demonstrate the extent of cardiac tumor, the extent 
of pericardial thickening, the mediastinal lymph node and 
the extracardiac lesions. These are helpful to distinguish pri-
mary pericardial tumors from the other cause of constrictive 
pericarditis, especially tuberculosis pericarditis. Mediastinal 
lymphadenopathy in patients with tuberculosis pericarditis 
has characteristically central low attenuation and coalescing 
of adjacent lymph nodes. In tuberculosis, pericarditis, aorto-
pulmonary, paratracheal, and carinal lymph node invasion 
is common, but hilar lymphadenopathy is rare.
5) The delayed 
phase image of CT scan or MRI is helpful to diagnose the 
pericardial tumor. In delayed phase image, pericardial soft 
tissue is distinguished from pericardial effusion. Furthermore, 
it is possible to observe hyperenhancement. These are useful 
to distinguish the primary pericardial tumors from tubercu-
lous pericarditis.
6) MRI is generally able to depict the tumor 
and its relation to surrounding cardiac structure.
7) In a recent 
report, PET-CT was useful in the staging and preoperative 
evaluation of pleural
8) or pericardial
9) mesothelioma, detec-
tion of unsuspected nodal and occult distant metastases. 
However, most cases of malignant pericardial mesothelioma 
have been diagnosed by histology, including immunohisto-
chemical staining after surgery or autopsy.
10) 
Malignant pericardial mesothelioma has poor prognosis 
and a progressive clinical course. Average survival was 10 
months regardless of therapy.
11) Moreover, standard treatment 
Fig. 3. A: chest CT demonstrated thickened pericardium with multiple pericardial nodules (arrow) and bilateral pleural effusion. B: PET-CT 
demonstrated significant FDG uptake in the pericardium (arrow) with a maximal standardized uptake value of 6.18. C: abdominal CT dem-
onstrated a 1.4 cm sized aortocarval lymphadenopathy (arrow). D: PET-CT demonstrated no significant FDG uptake in the aortocarval 
lymph node (arrow). PET: positron emission tomography, FDG: fluorodeoxyglucose. 
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Fig. 4. A: microscopic examination showed abundant pleomorphic malignant cells with epithelial appearance (H&E stain, ×400). B: positive 
immunochemical staining with calretinin.  
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has not been established. Curative surgical resection can be 
performed only in patients with localized disease. Palliative 
surgery, includes pericardiectomy, may prevent cardiac tam-
ponade and relieve pericardial constriction. In addition, pe-
ricardial mesothelioma responds poorly to radiation therapy. 
Recently, pemetrexed and carboplatin combination chemo-
therapy has demonstrated modest activity against malignant 
pleural mesothelioma as first line treatment.
12) Irinotecan has 
also been reported to demonstrate clinical activity against 
pleural mesothelioma in a clinical trial.
13)
In this case, because of ascites, pleural effusion and multi-
ple lymphadenopathy, we initially suspected malignancy with 
multiple systemic metastases. However, significant FDG up-
take in PET-CT was restricted in the pericardium. In retro-
spect, ascites and pleural effusion were only signs of pericar-
dial constriction. 
In conclusion, primary pericardial malignant mesothelio-
ma is an extremely rare neoplasm. Advanced malignant pe-
ricardial mesothelioma has no established treatment modal-
ity and is often misdiagnosed as other cause of constrictive 
pericarditis. Clinical suspicion is the most important factor 
to correct diagnosis and early detection of this disease. 
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